Back

Immunicum AB (publ) Announces Publication of Phase I/II Clinical Trial Results of Ilixadencel in Advanced Hepatocellular Carcinoma in Frontiers in Oncology

Keep reading

Immunicum’s nomination committee for the Annual General Meeting 2017 appointed

Read